Research & Development: Page 2


  • None
    Image attribution tooltip
    Stock via Getty Images

    Precision closes in on what could become the first 'off-the-shelf' CAR-T cell therapy

    Precision BioSciences’ CEO discusses the company’s potentially groundbreaking cancer treatment.

    By Kelly Bilodeau • July 7, 2022
  • None
    Image attribution tooltip
    Stock via Getty Images
    Q&A

    The CEO of Dr. Reddy's N. America is using 'controlled explosions' to keep the generics giant growing

    Marc Kikuchi weighs in on the company’s plans to pump up its pipeline and sales in the coming years.

    By July 7, 2022
  • None
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: CinCor Pharma's Terry Coelho

    From M&Ms to biotech, the chief financial officer's sweet tooth for taking risks is paying off. 

    By July 6, 2022
  • David Ross stands in the foreground, with glass windows behind him.
    Image attribution tooltip

    Permission granted by David Ross/Seqirus. 

    Dave Ross of Seqirus talks 'milestone' influenza vax vote

    In a unanimous decision, a CDC committee calls for a preferential flu vaccine recommendation for people aged 65 and older for the first time. 

    By Alexandra Pecci • July 5, 2022
  • None
    Image attribution tooltip
    Stock via Getty Images
    Q&A

    Biotech spotlight: Twist Bioscience aims to remove limits on drug discovery with DNA synthesis platform

    As ‘the Amazon of DNA,’ Twist CSO, Aaron Sato, discusses the company’s breakthrough approach to DNA production and its expansion into drug development.

    By Kim Ribbink • June 30, 2022
  • None
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Novartis' Marie-France Tschudin

    How the chief commercial officer and president of innovative medicines international plans to fuel growth and productivity at the company.

    By June 29, 2022
  • Katalin Kariko and Drew Weissman
    Image attribution tooltip
    Permission granted by University of Pennsylvania
    Q&A

    The scientist's struggle: Lessons from the journey of mRNA pioneers Katalin Karikó and Drew Weissman

    The two Penn Medicine researchers whose work brought the mRNA vaccines into COVID-19 fruition want to see the pharma world embrace early science.

    By June 29, 2022
  • Oral contraceptive pill on pharmacy counter with colorful pills strips background.
    Image attribution tooltip
    iStock via Getty Images

    With abortion access restricted across the U.S., a new diagnostic aims to eliminate birth control's pain points

    The hormonal and genetic test developed by Adyn is designed to predict and prevent adverse birth control side effects.

    By June 28, 2022
  • None
    Image attribution tooltip
    Stock via Getty Images

    The oncology market is surging despite a decline in routine screenings

    A new report from IQVIA reveals the current challenges — and promise — in cancer drug R&D.

    By Kelly Bilodeau • June 28, 2022
  • None
    Image attribution tooltip
    Stock via Getty Images

    4 tips for landing your next C-suite role in pharma

    Even execs get the blues — and when they’re ready for a fresh start, Leslie Loveless, CEO of Slone Partners, says these dos and don’ts could make or break their next job move.

    By June 23, 2022
  • None
    Image attribution tooltip

    Permission granted by Dan Vahdat.

    Q&A

    'Nobel Prize of pharma' helps put Huma's digital health platform on the global map

    The company’s CEO explains how its Prix Galien award-winning app bridges patient care, treatment support and clinical research.

    By Kim Ribbink • June 23, 2022
  • None
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Kronos Bio's Barbara Kosacz

    Deal-maker, mentor and biotech industry mover and shaker, the COO and general counsel brings her 'smiling tiger' skills to her new role at the emerging company.

    By June 21, 2022
  • Chicago skyline
    Image attribution tooltip
    Michael Gibney/PharmaVoice

    #DIA2022: How the industry's top regulator views the future of healthcare

    In the evolution of healthcare, data is the linchpin to making drug development more efficient.

    By June 21, 2022
  • schizophrenia
    Image attribution tooltip
    Stock via Getty Images
    Q&A

    Biotech spotlight: Karuna Therapeutics' mission to rejuvenate the field of neuroscience

    An effective treatment for psychiatric disorders such as schizophrenia might require a holistic approach to avoid serious side effects, says CEO Steve Paul.

    By Kim Ribbink • June 16, 2022
  • Boy in wheelchair
    Image attribution tooltip
    ChiccoDodiFC via Getty Images

    A patient-funded ALS drug offers hope where few treatments exist

    Eledon Pharmaceuticals’ grassroots-backed drug recently entered clinical trials.

    By Kelly Bilodeau • June 15, 2022
  • Image attribution tooltip
    Michael Ciaglo / Stringer via Getty Images
    Profile

    Buoyed by COVID-19 shot, J&J's vaccines head sees a new golden age approaching

    Janssen’s goal to have ‘a vaccine for the world’ is part of what drew Penny Heaton to the company and its work.

    By Alexandra Pecci • June 14, 2022
  • Scientist pipetting sample into a multi well plate
    Image attribution tooltip
    iStock via Getty Images
    Q&A

    Why biomanufacturing is the next innovation frontier for genomic therapies

    While cell and gene therapy research has accelerated quickly, manufacturing in the space hasn’t quite kept up, Danaher’s Chief Science Officer JC Gutiérrez-Ramos says.

    By June 13, 2022
  • Editas Medicine CEO Gilmore O'Neill
    Image attribution tooltip
    Permission granted by Editas/Gilmore O'Neill
    Q&A

    First 90 Days: Editas Medicine's Gilmore O'Neill

    The first-time CEO is flexing new muscles as he steers the gene editing company through clinical trials and beyond.

    By June 13, 2022
  • brain drug
    Image attribution tooltip
    Stock via Getty Images
    Q&A

    A combo of precision meds and diagnostics could disrupt mental healthcare

    HMNC Brain Health, a clinical-stage company, is leveraging cutting-edge tech to offer a new approach to mental health challenges.

    By Kelly Bilodeau • June 8, 2022
  • None
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Janssen's Najat Khan

    Janssen’s Najat Khan, Ph.D., chief data science officer and global head of strategy and operations, shares how the company is using next-gen tech to ‘reimagine’ medicine.

    By June 8, 2022
  • drug development
    Image attribution tooltip
    Stock via Getty Images
    Profile

    After losing her daughter to a rare disease, Sharon King is looking to rewrite the playbook of drug development

    The communications pro is lending her community-building, storytelling expertise to the Bespoke Gene Therapy Consortium.

    By Alexandra Pecci • June 7, 2022
  • The sun rises over the rural, Tennessee mountain town of Gatlinburg.
    Image attribution tooltip
    Jonathan Ross via Getty Images

    Pharma giants take on Appalachian cancer rates in newest screening initiative

    AstraZeneca and Bristol Myers Squibb are teaming up with the nonprofit Association of Community Cancer Centers to increase lung cancer screening in rural Appalachia for the long haul.

    By June 7, 2022
  • David Jimenez
    Image attribution tooltip

    Permission granted by David Jimenez.

    Q&A

    First 90 Days: Janssen Immunology's David Jimenez

    The long-time company man discusses the mega-drugmaker’s plans for growth and why, if you meet with him, you should plan on sipping coffee.

    By June 6, 2022
  • Merck senior vice president of early stage development in clinical oncology Eric Rubin
    Image attribution tooltip
    Permission granted by Merck/Eric Rubin

    How to build a cancer pipeline: Big Pharma oncology heads on driving science forward

    Executives leading the cancer departments at J&J, Merck and Takeda chime in on what it takes to construct a successful and sustainable oncology drug pipeline.

    By June 6, 2022
  • Avak Kahvejian
    Image attribution tooltip

    Permission granted by Flagship Pioneering/Avak Kahvejian.

    Profile

    Flagship's creative approach to finding the next big idea in biopharma

    Avak Kahvejian, partner at Flagship Pioneering, a company that conceives, creates and launches bioplatform companies like Moderna, discusses its latest venture, ProFound Therapeutics.

    By Alexandra Pecci • June 1, 2022